GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum

[1]  D. Souza,et al.  Guanine nucleotides inhibit the stimulation of GFAP phosphorylation by glutamate. , 1995, Neuroreport.

[2]  M. Caporali,et al.  Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats , 1994, Brain Research Bulletin.

[3]  D. Souza,et al.  Differential effects of guanine nucleotides on kainic acid binding and on adenylate cyclase activity in chick optic tectum , 1994, FEBS letters.

[4]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[5]  Y. Paas,et al.  A ligand binding study of the interactions of guanine nucleotides with non-NMDA receptors , 1993, Neurochemistry International.

[6]  R. Weinberg,et al.  Neurons in rat hippocampus that synthesize nitric oxide , 1993, The Journal of comparative neurology.

[7]  S. Nakanishi.  Molecular diversity of glutamate receptors and implications for brain function. , 1992, Science.

[8]  M. Beal,et al.  Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  C. J. Schmidt,et al.  Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo. , 1989, The Journal of pharmacology and experimental therapeutics.

[10]  R. Gill,et al.  Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  J. Monahan,et al.  Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions. , 1988, Molecular pharmacology.

[12]  Stanley J. Watson,et al.  The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.

[13]  A. Parent,et al.  Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons , 1987, Brain Research.

[14]  D. Choi,et al.  Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. , 1986, Science.

[15]  J. B. Martin,et al.  Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.

[16]  P. Emson,et al.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.

[17]  G. Lombardi,et al.  The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process , 1984, Neuroscience Letters.

[18]  T. Hökfelt,et al.  NADPH‐diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities , 1983, The Journal of comparative neurology.

[19]  S. W. Davies,et al.  No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid , 1987, Nature.